Wei‐Lien Chuang

1.7k total citations
28 papers, 1.1k citations indexed

About

Wei‐Lien Chuang is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Wei‐Lien Chuang has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 11 papers in Cell Biology and 9 papers in Molecular Biology. Recurrent topics in Wei‐Lien Chuang's work include Lysosomal Storage Disorders Research (18 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Wei‐Lien Chuang is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Wei‐Lien Chuang collaborates with scholars based in United States, France and Netherlands. Wei‐Lien Chuang's co-authors include Joan Keutzer, Dallas L. Rabenstein, Samantha Cooper, Joshua Pacheco, Ruhua Yang, Pramod K. Mistry, Seng H. Cheng, Carole Elbin, Jun Liu and Heather McAllister and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Wei‐Lien Chuang

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Lien Chuang United States 18 797 472 371 240 240 28 1.1k
Jan Lukáš Germany 19 904 1.1× 435 0.9× 338 0.9× 323 1.3× 326 1.4× 56 1.3k
Laura Gort Spain 24 758 1.0× 629 1.3× 282 0.8× 275 1.1× 221 0.9× 67 1.3k
Jakub Sikora Czechia 20 487 0.6× 507 1.1× 186 0.5× 137 0.6× 182 0.8× 48 1.1k
Amparo Chabás Spain 26 1.4k 1.8× 727 1.5× 690 1.9× 503 2.1× 435 1.8× 90 1.8k
Tina Rozaklis Australia 17 659 0.8× 236 0.5× 253 0.7× 145 0.6× 231 1.0× 24 835
Gouri Yogalingam Australia 20 617 0.8× 448 0.9× 266 0.7× 176 0.7× 393 1.6× 33 1.2k
Yoshiyuki Suzuki Japan 21 1.1k 1.3× 772 1.6× 259 0.7× 311 1.3× 287 1.2× 49 1.4k
N. U. Bosshard Switzerland 18 446 0.6× 338 0.7× 164 0.4× 223 0.9× 128 0.5× 27 972
André R. A. Marques Netherlands 18 641 0.8× 438 0.9× 331 0.9× 287 1.2× 289 1.2× 28 1.1k
Marta Deganuto Italy 15 327 0.4× 644 1.4× 158 0.4× 78 0.3× 92 0.4× 18 1.1k

Countries citing papers authored by Wei‐Lien Chuang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Lien Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Lien Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Lien Chuang more than expected).

Fields of papers citing papers by Wei‐Lien Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Lien Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Lien Chuang. The network helps show where Wei‐Lien Chuang may publish in the future.

Co-authorship network of co-authors of Wei‐Lien Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Lien Chuang. A scholar is included among the top collaborators of Wei‐Lien Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Lien Chuang. Wei‐Lien Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Wei‐Lien, et al.. (2019). Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients. Clinica Chimica Acta. 494. 48–51. 9 indexed citations
2.
Liu, Jun, Ruhua Yang, Haiqun Lin, et al.. (2016). Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Molecules and Diseases. 68. 47–53. 47 indexed citations
3.
Chuang, Wei‐Lien, Joshua Pacheco, & Kate Zhang. (2015). A Simple, High-Throughput Method for Analysis of Ceramide, Glucosylceramide, and Ceramide Trihexoside in Dried Blood Spots by LC/MS/MS. Methods in molecular biology. 1378. 263–272. 3 indexed citations
4.
Chuang, Wei‐Lien, Joshua Pacheco, Samantha Cooper, et al.. (2015). Improved sensitivity of an acid sphingomyelinase activity assay using a C6:0 sphingomyelin substrate. SHILAP Revista de lepidopterología. 3. 55–57. 5 indexed citations
5.
Dodge, James C., Christopher M. Treleaven, Joshua Pacheco, et al.. (2015). Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences. 112(26). 8100–8105. 102 indexed citations
6.
Ji, Allena, et al.. (2015). A Novel Approach for Quantitation of Glucosylceramide in Human Dried Blood Spot Using LC–MS/MS. Bioanalysis. 7(12). 1483–1496. 10 indexed citations
7.
8.
Mistry, Pramod K., Jun Liu, Li Sun, et al.. (2014). Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease. Proceedings of the National Academy of Sciences. 111(13). 4934–4939. 86 indexed citations
9.
Chuang, Wei‐Lien, Joshua Pacheco, Samantha Cooper, et al.. (2013). Lyso-sphingomyelin is elevated in dried blood spots of Niemann–Pick B patients. Molecular Genetics and Metabolism. 111(2). 209–211. 66 indexed citations
10.
Chuang, Wei‐Lien, Monica Martin, Joan Keutzer, et al.. (2013). Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clinica Chimica Acta. 419. 73–76. 52 indexed citations
11.
Nietupski, Jennifer B., Joshua Pacheco, Wei‐Lien Chuang, et al.. (2012). Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice. Molecular Genetics and Metabolism. 105(4). 621–628. 54 indexed citations
12.
Weeden, Timothy, Su Duan, Andrea E. Edling, et al.. (2010). A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity. Journal of Peptide Science. 17(1). 47–55. 6 indexed citations
13.
Ashe, Karen M., Kristin M. Taylor, K. Klinger, et al.. (2010). Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease. Molecular Genetics and Metabolism. 100(4). 309–315. 40 indexed citations
14.
Orsini, Joseph J., Mark A. Morrissey, Monica Martin, et al.. (2009). Implementation of newborn screening for Krabbe disease: Population study and cutoff determination. Clinical Biochemistry. 42(9). 877–884. 45 indexed citations
15.
Elbin, Carole, et al.. (2008). Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass Spectrometry. Clinical Chemistry. 54(10). 1725–1728. 135 indexed citations
16.
Nietupski, Jennifer B., Wei‐Lien Chuang, Donna Armentano, et al.. (2006). AAV8‐mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. The Journal of Gene Medicine. 8(6). 719–729. 49 indexed citations
17.
Chuang, Wei‐Lien, Heather McAllister, & Dallas L. Rabenstein. (2002). Hexasaccharides from the histamine-modified depolymerization of porcine intestinal mucosal heparin. Carbohydrate Research. 337(10). 935–945. 13 indexed citations
18.
19.
Chuang, Wei‐Lien, Heather McAllister, & Dallas L. Rabenstein. (2001). Chromatographic methods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin. Journal of Chromatography A. 932(1-2). 65–74. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Lukáš Breakdown of academic impact, for papers by Laura Gort Breakdown of academic impact, for papers by Jakub Sikora Breakdown of academic impact, for papers by Amparo Chabás Breakdown of academic impact, for papers by Tina Rozaklis Breakdown of academic impact, for papers by Gouri Yogalingam Breakdown of academic impact, for papers by Yoshiyuki Suzuki Breakdown of academic impact, for papers by N. U. Bosshard Breakdown of academic impact, for papers by André R. A. Marques Breakdown of academic impact, for papers by Marta Deganuto
Rankless by CCL
2026